Latest Insights on MU
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
No Fear Here: 4 Stocks to Beat the Wuhan Virus January 31, 2020 2020 Financial Crisis, Great Stuff Friday Four Play: The “Fear Inoculum” Edition (Did a friend forward you this email? If so, you owe them big-time! Seriously, this is Great Stuff. We don’t take that title lightly. After you’ve thanked your friend profusely, why not sign up for yourself today? It’s mostly painless. I promise.) The Wuhan coronavirus is officially a […]
Self-Driving Cars Are Coming: Invest Now for Huge Profits January 31, 2020 Investment Opportunities, Technology, Winning Investor Daily Goldman Sachs believes self-driving cars will be a $7 trillion market. And that massive disruption is closer than most expect…
Fixing Our Broken Economy January 31, 2020 Big Picture. Big Profits., Economy, U.S. Economy [17-minute video] The true conclusion of my series on anticompetitive practices in the U.S. 
Investors’ Survival Guide to the Coronavirus January 31, 2020 American Investor Today, Diversified Investments The coronavirus is spreading fear through global markets. But there is one beaten-down sector that will emerge from the global crisis even stronger. Anthony Planas reveals the No. 1 fund that every investor should add to their portfolio today.MEET OUR EXPERTS
Chief Strategist of Strategic Fortunes and three elite services
Founder of TRADEMONSTER.ai
Chief Investment Strategist of Money & Markets
Director of VIP Services
Founder of Weekend Trader
Research Analyst
